Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzoxonium
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Topical, Oral
01
Overview
Benzoxonium is a quaternary ammonium compound used as an antiseptic with antibacterial, antiviral, and antifungal (antimycotic) activity. It is primarily indicated for skin disinfection, prevention of infections, and disinfection of mucous membranes and instruments. Benzoxonium chloride is also used in the treatment of mouth and throat infections (such as gingivitis, mouth ulcers, and other oral infections), often administered as lozenges or topical preparations. Its mechanism of action involves inhibiting the growth of microorganisms by disrupting their cell membranes[1][2][4][7].
- Other names
- benzoxonium chloride
Beyond the preview
Go deeper on Benzoxonium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Benzoxonium.